Jonathan Lasham

Jonathan Lasham

Auto-generated profile, based on publicly available information

Jonathan Lasham

Department of Physics, University of Helsinki, FI-00014 Helsinki, Finland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2021 in Science Advances
Verified
Journal Article
Open access
KPKristian Parey
Kristian Parey
JLJonathan Lasham
Jonathan Lasham
DMDeryck J. Mills
Deryck J. Mills
ADAmina Djurabekova
Amina Djurabekova
OHOuti Haapanen
Outi Haapanen
VZVolker Zickermann
Volker Zickermann
High-resolution structure and molecular simulations unravel the inner workings of a redox-driven proton pump.

10 May 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
OZOleksii Zdorevskyi
Oleksii Zdorevskyi
ADAmina Djurabekova
Amina Djurabekova
JLJonathan Lasham
Jonathan Lasham
VSVivek Sharma
Vivek Sharma
Proton transfer in the membrane domain of complex I.

1 February 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SUShinpei Uno
Shinpei Uno
TMTakahiro Masuya
Takahiro Masuya
KSKyoko Shinzawa-Itoh
Kyoko Shinzawa-Itoh
JLJonathan Lasham
Jonathan Lasham
OHOuti Haapanen
Outi Haapanen
HMHideto Miyoshi
Hideto Miyoshi
NADH-quinone oxidoreductase (complex I) couples electron transfer from NADH to quinone with proton translocation across the membrane. Quinone reduction is a key step for energy transmission from the site of quinone reduction to the remotely located proton-pumping machinery of the enzyme. Although structural biology studies have proposed the existence of a long and narrow quinone-access channel, the physiological relevance of this channel remains debatable. We investigated here whether complex I in bovine heart submitochondrial particles (SMPs) can catalytically reduce a series of oversized ubiquinones (OS-UQs), which are highly unlikely to transit the narrow channel because their side chain includes a bulky "block" that is ∼13 Å across. We found that some OS-UQs function as efficient electron acceptors from complex I, accepting electrons with an efficiency comparable with ubiquinone-2. The catalytic reduction and proton translocation coupled with this reduction were completely inhibited by different quinone-site inhibitors, indicating that the reduction of OS-UQs takes place at the physiological reaction site for ubiquinone. Notably, the proton-translocating efficiencies of OS-UQs significantly varied depending on their side-chain structures, suggesting that the reaction characteristics of OS-UQs affect the predicted structural changes of the quinone reaction site required for triggering proton translocation. These results are difficult to reconcile with the current channel model; rather, the access path for ubiquinone may be open to allow OS-UQs to access the reaction site. Nevertheless, contrary to the observations in SMPs, OS-UQs were not catalytically reduced by isolated complex I reconstituted into liposomes. We discuss possible reasons for these contradictory results.

13 August 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
PKPatryk Kuleta
Patryk Kuleta
JLJonathan Lasham
Jonathan Lasham
MSMarcin Sarewicz
Marcin Sarewicz
IEIwona Ekiert
Iwona Ekiert
VSVivek Sharma
Vivek Sharma
AOArtur Osyczka
Artur Osyczka
Significance: To perform their specific electron-transfer relay functions, hemes commonly adopt low spin states with fine-tuned redox potentials. Understanding molecular elements controlling these properties is crucial for the description of natural proteins and engineering redox-active systems. We describe unusual effects of mitochondrial disease-related mutation in cytochrome bc 1 , based on which we identify a dual role of hydrogen bonding to the propionate group of heme b H . We observe that stabilization of the hydrogen bond in mutant enhances the redox potential but destabilizes the low spin state of oxidized heme. This demonstrates a critical role of the hydrogen bonding, and heme-protein interactions in general, to secure a suitable redox potential and spin state, a notion that might be universal for other heme proteins.

14 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
LHLiina Hannula
Liina Hannula
SKSuvi Kuivanen
Suvi Kuivanen
JLJonathan Lasham
Jonathan Lasham
Ravi KantRavi Kant
Ravi Kant
LKLauri Kareinen
Lauri Kareinen
IRIlona Rissanen
Ilona Rissanen
In response to the ongoing SARS-CoV-2 pandemic, the quest for coronavirus inhibitors has inspired research on a variety of small proteins beyond conventional antibodies, including robust single-domain antibody fragments, ‘nanobodies’. Here, we explore the potential of nanobody engineering in the development of antivirals and diagnostic tools. Through fusion of nanobody domains that target distinct binding sites, we engineered multimodular nanobody constructs that neutralize wild-type SARS-CoV-2 and the Alpha and Delta variants with high potency, with IC50 values up to 50 pM. However, we observed a limitation in the efficacy of multimodular nanobodies against the Beta (B.1.351) and Omicron variants (B.1.1.529), underlining the importance of accounting for viral evolution in the design of biologics. To further explore the applications of nanobody engineering in outbreak management, we present a novel detection assay, based on fusions of nanobodies with fragments of NanoLuc luciferase that can detect sub-nanomolar quantities of the SARS-CoV-2 spike protein in a single step. Our work showcases the potential of nanobody engineering to combat emerging infectious disease.